Sunday, September 19, 2021
- Advertisement -spot_img


Laurus Labs

Laurus Labs registers multi-fold growth

Hyderabad-based company’s revenues for FY21 stood at Rs 4,814 crore, up 70 per cent Y-o-Y while its profit jumped 286 per cent to Rs 984 crore Y-o-Y

Laurus Labs wins Golden Peacock Award

Instituted in 1991 by the Institute of Directors (IOD), India, the Golden Peacock Award is regarded as a global recognition for corporate excellence.

Laurus Labs posts net profit at Rs 273 crore

The company’s revenue grew by 76 per cent at Rs 1,288 crore as against Rs 730 crore in the year-ago period.

Laurus to acquire majority stake in Richcore

Hyderabad-based company to acquire 72.55% stake in Bengaluru biotech firm for over Rs 246 crore

Laurus Labs Q2 net profit up 325% year-on-year

The company’s revenue for the first half of the fiscal went up to Rs 2,113 crore, up 67 per cent Y-o-Y, while net profit jumped 475 per cent to Rs 414 crore Y-o-Y.

80 per cent investment proposals operationalised: KTR

Minister said the State government was attracting investments even during the Covid-19 pandemic due to its continuous efforts over a period of time

Hyderabad attracts Rs 700 crore investments in pharma

Granules India, Laurus Labs to set up new manufacturing facilities for finished dosages and formulations, respectively

‘Pharma City offers talent, infra for investors’

The upcoming Hyderabad Pharma City will give further boost to companies that are planning to invest in Hyderabad for both greenfield and brownfield expansion, says an expert.

Laurus Labs Q1 profit at Rs 172 crore

Hyderabad: Hyderabad-based Laurus Labs has reported a net profit of Rs 172 crore for the quarter ended June 2020. The company’s revenues went up...

Hyderabad: Laurus Labs receives US FDA nod for AIDS drugs

Hyderabad firm aims to cater to low-to-middle-income-countries

Laurus Labs registers highest ever profit at Rs 255.3 cr in FY20

Hyderabad-based pharmaceutical company records 172 per cent growth in profit year-on-year

Laurus Labs registers highest ever profit at Rs 255.3 cr in FY20

The company reported a net profit of Rs 110.2 crore for the fourth quarter (January-March FY20), an increase of 155 per cent over the corresponding quarter of the previous year. Revenues for the quarter went up by 32 per cent

India can meet global demand for anti-malarial drug: Uday Bhaskar

Hydroxychloroquine capacity to be scaled up from 30 to 35 tonnes per month to over 50 tonnes shortly

IKP fostering innovation

Developing a Sustainability Innovation Centre, SME Hub and Tech Transfer Cell

Laurus Labs’ PAT jumps to Rs 57 crore in Q2

CEO of Laurus Labs Satyanarayana Chava said that the performance during the quarter shows the ability to execute the long-term strategy of the company with enhanced revenue from formulations business contributing positively to both topline and margins

Telangana aims to double life sciences sector to $100 bn

State attracts investments of about Rs 10,222 crores

Laurus Labs net profit up 17.5%

CEO said, “We are on track to achieve our long term goals. Our focal aim on innovation has helped us provide affordable and quality pharmaceutical solutions."

Latest news

- Advertisement -spot_img
Telangana Today